Although all participants lacked N antigen seroreactivity, AIM T cell responses against N peptides were detected in the CD8+ T cells of 1 healthy control and the CD4+ T cells of 3 CLL patients (S7B Table), likely representing responses to prior endemic HCoV infections [54,55]. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.